A Provider-Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation.
Journal
Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
14
09
2022
received:
02
12
2021
accepted:
03
11
2022
medline:
28
6
2023
pubmed:
8
11
2022
entrez:
7
11
2022
Statut:
ppublish
Résumé
Substantial disparities exist in clinical trial participation, which is problematic in diseases such as lupus that disproportionately affect racial/ethnic minority populations. Our objective was to examine the effectiveness of an online educational course aiming to train medical providers to refer Black and Latino patients to lupus clinical trials (LCTs). The American College of Rheumatology's Materials to Increase Minority Involvement in Clinical Trials (MIMICT) study used an online, randomized, 2-group, pretest/posttest design with medical and nursing providers of multiple specialties. We exposed intervention group participants to an education course, while the control group participants received no intervention. Controlling for the effects of participant characteristics, including specialty, and professional experience with lupus, we modeled relationships among exposure to the education course and changes in knowledge, attitudes, self-efficacy, and intentions to refer Black and Latino patients to LCTs. We also examined education course satisfaction. Compared to the control group, the intervention group had significantly higher posttest scores for knowledge, self-efficacy, and intentions to refer Black and Latino patients to LCTs. Both medical and nursing trained intervention group participants had significantly higher mean posttest scores for knowledge and intentions to refer compared to the medical and nursing trained control group participants. Attitude was insignificant in analysis. The online education course, which received a favorable summary score, indicated that satisfaction and intentions to refer were strongly and positively correlated. The MIMICT education course is an effective method to educate medical providers about LCTs and to improve their intentions to refer Black and Latino patients.
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1434-1442Informations de copyright
© 2022 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
Références
Sheikh S. Diversity in lupus clinical trials: why is it important? 2019. URL: https://www.consultant360.com/exclusive/rheumatology/lupus/diversity-lupus-clinical-trials-why-it-important.
Chakravarty EF, Bush TM, Manzi S, et al. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-6.
Centers for Disease Control and Prevention. Lupus basics. 2018. URL: http://bit.ly/2ngAOoB.
Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.
Gonzalez LA, Toloza SM, McGwin G Jr, et al. Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus 2013;22:1214-24.
Centers for Disease Control and Prevention. Trends in deaths from systemic lupus erythematosus: United States, 1979-1998. MMWR Morb Mortal Wkly Rep 2002;51:371-4.
Gianfrancesco MA, Dall'Era M, Murphy LB, et al. Mortality among minority populations with systemic lupus erythematosus, including Asian and Hispanic/Latino persons: California, 2007-2017. MMWR Morb Mortal Wkly Rep 2021;70:236-9.
Gomez-Puerta JA, Vasquez G. What impact do race and ethnicity have on lupus mortality? Int J Clin Rheumatol 2015;10:223-6.
Hamel LM, Penner LA, Albrecht TL, et al. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 2016;23:327-37.
Langford AT, Bateman-House A. Clinical trials for COVID-19: populations most vulnerable to COVID-19 must be included. 2020. URL: https://www.healthaffairs.org/do/10.1377/forefront.20200609.555007.
Sheikh SZ, Wanty NI, Stephens J, et al. The state of lupus clinical trials: minority participation needed. J Clin Med 2019;8:1245.
Korieth K. Engaging healthcare providers as research facilitators. CenterWatch Monthly 2016;23:1-5.
Van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med 2000;50:813-28.
Mills EJ, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 2006;7:141-8.
The Lupus Initiative from the American College of Rheumatology. Materials to increase minority involvement in clinical trials. 2022. URL: https://thelupusinitiative.org/mimict-2/.
Azjen I, Albarracin D, Hornik R. Prediction and change of health behavior: applying the reasoned action approach. 1st ed. Mahwah (NJ): Lawrence Erlbaum; 2007.
Azjen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211.
Azjen I, Fishbein M. Attitude-behavior relations: a theoretical analysis and review of empirical research. Psychol Bull 1977;84:888-918.
Schneider CD, Meek PM, Bell IR. Development and validation of IMAQ: Integrative Medicine Attitude Questionnaire. BMC Med Educ 2003;3:5.
De Maesschalck S, Willems S, De Maeseneer J, et al. Development and validation of EMP-3: an instrument to measure physicians' attitudes towards ethnic minority patients. Fam Med 2010;42:262-7.
Lam WY, Gunukula SK, McGuigan D, et al. Validated instruments used to measure attitudes of healthcare students and professionals towards patients with physical disability: a systematic review. J Neuroeng Rehabil 2010;7:55.
Schwarzer R, Jerusalem M. General self-efficacy scale. Windsor (IL): NFER-NELSON; 1995.
Francis JJ, Eccles MP, Johnston M, et al. Constructing questionnaires based on the theory of planned behavior: a manual for health services researchers. Newcastle upon Tyne (UK): University of Newcastle upon Tyne; 2004.
Goodman MS, Si X, Stafford JD, et al. Quantitative assessment of participant knowledge and evaluation of participant satisfaction in the CARES training program. Prog Community Health Partnersh 2012;6:361-8.
Viswanathan M, Ammerman A, Eng E, et al. Community-based participatory research: assessing the evidence. Evid Rep Technol Assess (Summ) 2004;99:1-8.
Williams EM, Egede L, Oates JC, et al. Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial. Trials 2019;20:529.
Lupus Foundation of America. IMPACT for Lupus. 2021. URL: https://www.lupus.org/for-researchers/improving-minority-participation-and-awareness-in-clinical-trials.
Miller J. (Un)intended consequences unconscious bias hurts individuals on both sides of the white coat. Harvard Medicine. 2017. URL: https://hms.harvard.edu/magazine/connections/unintended-consequences.
The Society for Women's Health Research. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. Washington (DC): Food and Drug Administration, Office of Women's Health; 2011.
Vesely S, Klöckner CA. Social desirability in environmental psychology research: three meta-analyses. Front Psychol 2020;11:1395.
The Association of Clinical Research Professionals, Chambers J, Fujimoto N. Identifying new ways to increase participation in clinical trials. 2018. URL: https://acrpnet.org/2018/02/06/identifying-new-ways-increase-participation-clinical-trials/.
Ignatowicz A, Greenfield G, Pappas Y, et al. Achieving provider engagement: providers' perceptions of implementing and delivering integrated care. Qual Health Res 2014;24:1711-20.